cellsighttech.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: gsa-crawler Crawl-delay: 7 Disallow: /intranet/ User-agent: * Crawl-delay: 7 Disallow: | ||
Meta Tags
| Title | Welcome to CellSight Technologies - Imaging Immune |
| Description | CellSight Technologies, CellSight Technologies, Inc. Technology Clinical Trials About Us Contact Us Whole body immune response to immunotherapy can be seen with VisAcT ® PET trac |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 66.96.149.18 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cellsighttech.com Valuation
|
US$1,771,593
Last updated: 2023-05-17 07:18:16
cellsighttech.com has Semrush global rank of 5,974,458. cellsighttech.com has an estimated worth of US$ 1,771,593, based on its estimated Ads revenue. cellsighttech.com receives approximately 204,415 unique visitors each day. Its web server is located in United States, with IP address 66.96.149.18. According to SiteAdvisor, cellsighttech.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,771,593 |
| Daily Ads Revenue | US$1,636 |
| Monthly Ads Revenue | US$49,060 |
| Yearly Ads Revenue | US$588,714 |
| Daily Unique Visitors | 13,628 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cellsighttech.com. | A | 3600 | IP: 66.96.149.18 |
| cellsighttech.com. | NS | 3600 | NS Record: ns1.startlogic.com. |
| cellsighttech.com. | NS | 3600 | NS Record: ns2.startlogic.com. |
| cellsighttech.com. | MX | 3600 | MX Record: 30 mx.cellsighttech.com. |
| cellsighttech.com. | TXT | 3600 | TXT Record: v=spf1 ip4:66.96.128.0/18 ?all |
HtmlToTextCheckTime:2023-05-17 07:18:16
| CellSight Technologies, Inc. Technology Clinical Trials About Us Contact Us Whole body immune response to immunotherapy can be seen with VisAcT ® PET tracer. In Phase II clinical trials at multiple sites. Imaging tools to visualize immune response effective and a few may develop adverse reaction to the immunotherapy. CellSight’s PET tracer can help determine if a patient is immune ready or needs immune priming prior to the start of immunotherapy. Additionally, an on-treatment scan can help assess immunotherapy response early in the treatment cycle. Cancer immunotherapies that harness the body’s immune system to help fight cancer do not work for everyone; in fact, success rates can be as low as 20%! Many patients seem to get worse before symptoms ease and clinical benefit can be observed. Some patients may discontinue treatment too early, some continue treatment even though it may not be Latest News February 1, 2022 Immunooncology Symposium, Center for Translation Cancer Research, |
HTTP Headers
HTTP/1.1 200 OK Date: Sat, 12 Mar 2022 08:25:10 GMT Content-Type: text/html Content-Length: 9311 Connection: keep-alive Server: Apache/2 Accept-Ranges: bytes Age: 0 |
cellsighttech.com Whois Information
Domain Name: CELLSIGHTTECH.COM Registry Domain ID: 1298807478_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-10-11T13:35:12Z Creation Date: 2007-10-26T06:00:40Z Registry Expiry Date: 2022-10-26T06:00:40Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.STARTLOGIC.COM Name Server: NS2.STARTLOGIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-12T08:28:19Z <<< |